Huntington National Bank Boosts Holdings in Corteva, Inc. (NYSE:CTVA)

Huntington National Bank increased its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 342,340 shares of the company's stock after purchasing an additional 7,408 shares during the quarter. Huntington National Bank's holdings in Corteva were worth $19,500,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in CTVA. Flagship Wealth Advisors LLC purchased a new stake in Corteva in the fourth quarter worth about $25,000. Noble Wealth Management PBC purchased a new stake in shares of Corteva in the 4th quarter worth approximately $26,000. Hager Investment Management Services LLC bought a new position in Corteva during the 4th quarter valued at approximately $27,000. Golden State Wealth Management LLC purchased a new position in Corteva during the fourth quarter valued at $32,000. Finally, Centricity Wealth Management LLC bought a new stake in Corteva in the fourth quarter worth $34,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

NYSE:CTVA traded down $5.64 on Friday, hitting $55.66. The stock had a trading volume of 6,391,602 shares, compared to its average volume of 3,244,036. The business's 50-day simple moving average is $62.36 and its two-hundred day simple moving average is $60.26. The stock has a market cap of $38.02 billion, a price-to-earnings ratio of 43.15, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. Corteva, Inc. has a 52-week low of $50.01 and a 52-week high of $66.24. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08.

Remove Ads

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, research analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a $0.17 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.22%. Corteva's dividend payout ratio (DPR) is 52.71%.

Insider Buying and Selling

In related news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.14% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Royal Bank of Canada lifted their price target on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research report on Friday, February 7th. Barclays lifted their target price on shares of Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 21st. UBS Group dropped their target price on shares of Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Oppenheimer raised their price target on shares of Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a research report on Friday, February 7th. Finally, Citigroup upped their price objective on Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and an average price target of $68.06.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.